Literature DB >> 27966270

Comparison of targeted proteomics approaches for detecting and quantifying proteins derived from human cancer tissues.

Jakub Faktor1, Rita Sucha2, Vendula Paralova3, Yansheng Liu4, Pavel Bouchal1,3.   

Abstract

Targeted mass spectrometry-based proteomics approaches enable the simultaneous and reproducible quantification of multiple protein analytes across numerous conditions in biology and clinical studies. These approaches involve e.g. selected reaction monitoring (SRM) typically conducted on a triple quadrupole mass spectrometer, its high-resolution variant named pseudo-SRM (p-SRM), carried out in a quadrupole coupled with an TOF analyzer (qTOF), and "sequential window acquisition of all theoretical spectra" (SWATH). Here we compared these methods in terms of signal-to-noise ratio (S/N), coefficient of variance (CV), fold change (FC), limit of detection and quantitation (LOD, LOQ). We have shown the highest S/N for p-SRM mode, followed by SRM and SWATH, demonstrating a trade-off between sensitivity and level of multiplexing for SRM, p-SRM, and SWATH. SRM was more sensitive than p-SRM based on determining their LOD and LOQ. Although SWATH has the worst S/N, it enables peptide multiplexing with post-acquisition definition of the targets, leading to better proteome coverage. FC between breast tumors of different clinical-pathological characteristics were highly correlated (R2 >0.97) across three methods and consistent with the previous study on 96 tumor tissues. Our technical note presented here, therefore, confirmed that outputs of all the three methods were biologically relevant and highly applicable to cancer research.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cancer; MRM/SRM; SWATH; Tissue; p-SRM

Mesh:

Substances:

Year:  2017        PMID: 27966270     DOI: 10.1002/pmic.201600323

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  5 in total

1.  Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE Tumor Biopsies for Molecular Diagnostics.

Authors:  Yeoun Jin Kim; Steve M M Sweet; Jarrett D Egertson; Andrew J Sedgewick; Sunghee Woo; Wei-Li Liao; Gennifer E Merrihew; Brian C Searle; Charlie Vaske; Robert Heaton; Michael J MacCoss; Todd Hembrough
Journal:  J Proteome Res       Date:  2018-12-12       Impact factor: 4.466

Review 2.  Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  J Proteomics       Date:  2018-02-13       Impact factor: 4.044

3.  Breast Cancer Classification Based on Proteotypes Obtained by SWATH Mass Spectrometry.

Authors:  Pavel Bouchal; Olga T Schubert; Jakub Faktor; Lenka Capkova; Hana Imrichova; Karolina Zoufalova; Vendula Paralova; Roman Hrstka; Yansheng Liu; Holger Alexander Ebhardt; Eva Budinska; Rudolf Nenutil; Ruedi Aebersold
Journal:  Cell Rep       Date:  2019-07-16       Impact factor: 9.423

4.  Molecular signatures that can be transferred across different omics platforms.

Authors:  M Altenbuchinger; P Schwarzfischer; T Rehberg; J Reinders; Ch W Kohler; W Gronwald; J Richter; M Szczepanowski; N Masqué-Soler; W Klapper; P J Oefner; R Spang
Journal:  Bioinformatics       Date:  2017-07-15       Impact factor: 6.937

5.  LINE-1 ORF2p expression is nearly imperceptible in human cancers.

Authors:  Daniel Ardeljan; Xuya Wang; Mehrnoosh Oghbaie; Martin S Taylor; David Husband; Vikram Deshpande; Jared P Steranka; Mikhail Gorbounov; Wan Rou Yang; Brandon Sie; H Benjamin Larman; Hua Jiang; Kelly R Molloy; Ilya Altukhov; Zhi Li; Wilson McKerrow; David Fenyö; Kathleen H Burns; John LaCava
Journal:  Mob DNA       Date:  2019-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.